The global healthcare industry experienced a 6% decline in the number of cybersecurity-related patent applications in Q2 2024 compared with the previous quarter. The total number of cybersecurity-related grants dropped by 3% in Q2 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Healthcare: Patents Trends Q2 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of cybersecurity-related patent applications in the healthcare industry was 594 in Q2 2024, versus 635 in the prior quarter.
The top five companies accounted for 12% of patenting activity
Analysis of patenting activity by companies shows that Abbott Laboratories filed the most cybersecurity patents within the healthcare industry in Q2 2024. The company filed 26 cybersecurity-related patents in the quarter, compared with 26 in the previous quarter. It was followed by Johnson & Johnson with 18 cybersecurity patent filings, DexCom (13 filings), and Samsung Group (11 filings) in Q2 2024.
Patenting activity was driven by the US with a 34% share of total patent filings
The largest share of cybersecurity related patent filings in the healthcare industry in Q2 2024 was in the US with 34%, followed by China (30%) and Japan (3%). The share represented by the US was 2% lower than the 36% share it accounted for in Q1 2024.
For further understanding of GlobalData's Healthcare: Patents Trends Q2 2024, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.